David Shulkin sets out very clearly that this week’s proposed deal means additional funding will be approved for the VA. Even winning a small piece of the “mandatory” PACT Act expenditure of USD 20.3 billion pie in FY2024 (a USD 15.3 billion increase) on toxic exposures would be company changing for 4DX - yet just a drop in the ocean for the VA. Let’s go team!
Research, page-1576
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.5¢ |
Change
0.015(2.50%) |
Mkt cap ! $252.4M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 61.5¢ | 58.0¢ | $535.1K | 886.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 241800 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.5¢ | 7110 | 2 |
View Market Depth
| Last trade - 13.34pm 02/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |